Trials / Unknown
UnknownNCT02551848
Kinematic-based BoNT-A Injections for Bilateral ET
Botulinum Toxin Type A for Injection of Bilateral Upper Extremity Tremor in Patients With Essential Tremor Using Kinematic Assessment
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Western University, Canada · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to study the efficacy of botulinum toxin type A (Xeomin®) injected utilizing kinematically-based injection parameters for the treatment of upper extremity essential tremor (ET). Additional objectives are to study the benefit of kinematic assessment tools in determining injection parameters and to study the composition of tremor using kinematics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botulinum toxin type A |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2020-09-01
- Completion
- 2021-12-01
- First posted
- 2015-09-16
- Last updated
- 2020-06-22
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02551848. Inclusion in this directory is not an endorsement.